drugset / Trial / NCT07543146

Effectiveness of Serratiopeptidase After Mandibular Third Molar Surgery

NCT07543146

Completed 110 enrolled Sharif Medical Research Center
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial was conducted to compare the effect of serratiopeptidase versus no intervention on postoperative mouth opening, swelling, and trismus following surgical removal of mesioangular mandibular third molars.

Timeline

Start
2025-06-06
Primary completion
2025-09-02
Completion
2025-09-02

Drugs

EvaluationDrugModalityDoseRoute
Subject serrapeptase Protein / enzyme biologic

Indications

No indication recorded.